BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 19380666)

  • 1. alpha-Melanocyte-stimulating hormone-induced eruptive nevi.
    Cardones AR; Grichnik JM
    Arch Dermatol; 2009 Apr; 145(4):441-4. PubMed ID: 19380666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical melanocytic naevi following melanotan injection.
    Reid C; Fitzgerald T; Fabre A; Kirby B
    Ir Med J; 2013 May; 106(5):148-9. PubMed ID: 23914578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eruptive melanocytic naevi following melanotan injection.
    Cousen P; Colver G; Helbling I
    Br J Dermatol; 2009 Sep; 161(3):707-8. PubMed ID: 19575725
    [No Abstract]   [Full Text] [Related]  

  • 4. [Melanotan-induced lentigines and nevi].
    Thestrup-Pedersen K; Søndergaard K
    Ugeskr Laeger; 2011 Mar; 173(13):975. PubMed ID: 21453640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Eruptive dysplastic nevi following melanotan use].
    Hueso-Gabriel L; Mahiques Santos L; Terrádez Mas L; Santonja López N
    Actas Dermosifiliogr; 2012 May; 103(4):329-31. PubMed ID: 22425244
    [No Abstract]   [Full Text] [Related]  

  • 6. [Eruptive nevi after injection of drugs marketed as melanotan II. The first two Swedish cases described].
    Burian E; Burian E
    Lakartidningen; 2013 Jan 30-Feb 5; 110(5):208-10. PubMed ID: 23451671
    [No Abstract]   [Full Text] [Related]  

  • 7. Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II.
    Schulze F; Erdmann H; Hardkop LH; Anemüller W; Rose C; Zillikens D; Fischer TW
    Eur J Dermatol; 2014; 24(1):107-9. PubMed ID: 24334249
    [No Abstract]   [Full Text] [Related]  

  • 8. An eruptive pigmented lesion after melanotan injection.
    Ferrándiz-Pulido C; Fernández-Figueras MT; Quer A; Ferrándiz C
    Clin Exp Dermatol; 2011 Oct; 36(7):801-2. PubMed ID: 21933235
    [No Abstract]   [Full Text] [Related]  

  • 9. Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: Nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma.
    Rokuhara S; Saida T; Oguchi M; Matsumoto K; Murase S; Oguchi S
    J Am Acad Dermatol; 2004 May; 50(5):695-700. PubMed ID: 15097952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change in moles linked to use of unlicensed "sun tan jab".
    Langan EA; Ramlogan D; Jamieson LA; Rhodes LE
    BMJ; 2009 Jan; 338():b277. PubMed ID: 19174439
    [No Abstract]   [Full Text] [Related]  

  • 11. [Expression of galanin in melanocytic tumors].
    Gilaberte Y; Vera J; Coscojuela C; Roca MJ; Parrado C; González S
    Actas Dermosifiliogr; 2007; 98(1):24-34. PubMed ID: 17374330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanotan-associated melanoma in situ.
    Ong S; Bowling J
    Australas J Dermatol; 2012 Nov; 53(4):301-2. PubMed ID: 22724573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi).
    Ko CJ; McNiff JM; Glusac EJ
    J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of total body photography on biopsy rate in patients from a pigmented lesion clinic.
    Risser J; Pressley Z; Veledar E; Washington C; Chen SC
    J Am Acad Dermatol; 2007 Sep; 57(3):428-34. PubMed ID: 17624623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.
    Habbema L; Halk AB; Neumann M; Bergman W
    Int J Dermatol; 2017 Oct; 56(10):975-980. PubMed ID: 28266027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eruptive Melanocytic Nevi: A Review.
    Burian EA; Jemec GBE
    Am J Clin Dermatol; 2019 Oct; 20(5):669-682. PubMed ID: 31119650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanotan-associated melanoma.
    Paurobally D; Jason F; Dezfoulian B; Nikkels AF
    Br J Dermatol; 2011 Jun; 164(6):1403-5. PubMed ID: 21564053
    [No Abstract]   [Full Text] [Related]  

  • 18. Eruptive post-chemotherapy in situ melanomas and dysplastic nevi.
    Reutter JC; Long EM; Morrell DS; Thomas NE; Groben PA
    Pediatr Dermatol; 2007; 24(2):135-7. PubMed ID: 17461808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Eruptive melanocytic nevi after chemotherapy].
    Karrer S; Szeimies RM; Stolz W; Landthaler M
    Klin Padiatr; 1998; 210(1):43-6. PubMed ID: 9522304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocytic lesions of the genital area with attention given to atypical genital nevi.
    Ribé A
    J Cutan Pathol; 2008 Nov; 35 Suppl 2():24-7. PubMed ID: 18976416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.